ETHICON RECALLING 396 LOTS OF VICRYL SUTURES
This article was originally published in The Gray Sheet
Executive SummaryETHICON RECALLING 396 LOTS OF VICRYL SUTURES in response to sterility problems. The recall pertains to coated polyglactin Vicryl sutures manufactured at the Johnson & Johnson subsidiary's San Angelo, Texas suture manufacturing facility between late March and early May, the company says.
You may also be interested in...
Less-invasive technologies to treat benign prostatic hyperplasia are fast becoming viable alternatives to medication and surgery. Here's what one researcher in the area, Steven Raman, had to say about the new options.
Novartis’s first digital innovation hub in Asia is launched in India, where the Swiss company hopes to ally with partners to deliver digital solutions for patients at scale.
Senate Finance Committee’s approach to penalize companies for raising WAC list prices is not a ‘price control,’ but a reasonable approach to change the incentives that distort pricing in the supply chain, US HHS Secretary Alex Azar says.